255 related articles for article (PubMed ID: 24643650)
1. State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.
Ghebre RG; Jones LA; Wenzel JA; Martin MY; Durant RW; Ford JG
Cancer; 2014 Apr; 120 Suppl 7(0 7):1122-30. PubMed ID: 24643650
[TBL] [Abstract][Full Text] [Related]
2. Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials.
Fouad MN; Acemgil A; Bae S; Forero A; Lisovicz N; Martin MY; Oates GR; Partridge EE; Vickers SM
J Oncol Pract; 2016 Jun; 12(6):556-63. PubMed ID: 27189356
[TBL] [Abstract][Full Text] [Related]
3. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
[TBL] [Abstract][Full Text] [Related]
4. A lay patient navigation training curriculum targeting disparities in cancer clinical trials.
Bryant DC; Williamson D; Cartmell K; Jefferson M
J Natl Black Nurses Assoc; 2011 Dec; 22(2):68-75. PubMed ID: 23061182
[TBL] [Abstract][Full Text] [Related]
5. Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review.
Nouvini R; Parker PA; Malling CD; Godwin K; Costas-Muñiz R
Cancer; 2022 Nov; 128(21):3860-3869. PubMed ID: 36107740
[TBL] [Abstract][Full Text] [Related]
6. Involving American Indians and medically underserved rural populations in cancer clinical trials.
Guadagnolo BA; Petereit DG; Helbig P; Koop D; Kussman P; Fox Dunn E; Patnaik A
Clin Trials; 2009 Dec; 6(6):610-7. PubMed ID: 19933720
[TBL] [Abstract][Full Text] [Related]
7. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Cruz-Flores S; Rabinstein A; Biller J; Elkind MS; Griffith P; Gorelick PB; Howard G; Leira EC; Morgenstern LB; Ovbiagele B; Peterson E; Rosamond W; Trimble B; Valderrama AL; ; ; ;
Stroke; 2011 Jul; 42(7):2091-116. PubMed ID: 21617147
[TBL] [Abstract][Full Text] [Related]
8. Satisfaction with cancer care among underserved racial-ethnic minorities and lower-income patients receiving patient navigation.
Jean-Pierre P; Cheng Y; Wells KJ; Freund KM; Snyder FR; Fiscella K; Holden AE; Paskett ED; Dudley DJ; Simon MA; Valverde PA;
Cancer; 2016 Apr; 122(7):1060-7. PubMed ID: 26849163
[TBL] [Abstract][Full Text] [Related]
9. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
10. An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual.
Vickers SM; Fouad MN
Cancer; 2014 Apr; 120 Suppl 7(0 7):1087-90. PubMed ID: 24643645
[No Abstract] [Full Text] [Related]
11. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.
Steinberg ML; Fremont A; Khan DC; Huang D; Knapp H; Karaman D; Forge N; Andre K; Chaiken LM; Streeter OE
Cancer; 2006 Dec; 107(11):2669-77. PubMed ID: 17078056
[TBL] [Abstract][Full Text] [Related]
12. Overcoming Barriers: Evidence-Based Strategies to Increase Enrollment of Underrepresented Populations in Cancer Therapeutic Clinical Trials-a Narrative Review.
Vuong I; Wright J; Nolan MB; Eggen A; Bailey E; Strickland R; Traynor A; Downs T
J Cancer Educ; 2020 Oct; 35(5):841-849. PubMed ID: 31713103
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).
Durant RW; Wenzel JA; Scarinci IC; Paterniti DA; Fouad MN; Hurd TC; Martin MY
Cancer; 2014 Apr; 120 Suppl 7(0 7):1097-105. PubMed ID: 24643647
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.
Flores LE; Frontera WR; Andrasik MP; Del Rio C; Mondríguez-González A; Price SA; Krantz EM; Pergam SA; Silver JK
JAMA Netw Open; 2021 Feb; 4(2):e2037640. PubMed ID: 33606033
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of patient navigation programs for adult cancer patients undergoing treatment: a systematic review.
Tho PC; Ang E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):295-321. PubMed ID: 27536800
[TBL] [Abstract][Full Text] [Related]
16. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.
Hawk ET; Habermann EB; Ford JG; Wenzel JA; Brahmer JR; Chen MS; Jones LA; Hurd TC; Rogers LM; Nguyen LH; Ahluwalia JS; Fouad M; Vickers SM
Cancer; 2014 Apr; 120 Suppl 7(0 7):1113-21. PubMed ID: 24643649
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled dissemination study of community-to-clinic navigation to promote CRC screening: Study design and implications.
Larkey L; Szalacha L; Herman P; Gonzalez J; Menon U
Contemp Clin Trials; 2017 Feb; 53():106-114. PubMed ID: 27940183
[TBL] [Abstract][Full Text] [Related]
18. Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.
Nonzee NJ; McKoy JM; Rademaker AW; Byer P; Luu TH; Liu D; Richey EA; Samaras AT; Panucci G; Dong X; Simon MA
BMC Health Serv Res; 2012 Sep; 12():340. PubMed ID: 23009152
[TBL] [Abstract][Full Text] [Related]
19. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
Nemala A; Ullah A; Yacur M; Karim NA
Clin Lung Cancer; 2023 Nov; 24(7):573-580. PubMed ID: 37574437
[TBL] [Abstract][Full Text] [Related]
20. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
